Related references
Note: Only part of the references are listed.Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target
Ninib Baryawno et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice
Shao-An Xue et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting Tyrosinase
Timothy L. Frankel et al.
JOURNAL OF IMMUNOLOGY (2010)
Minimal Amino Acid Exchange in Human TCR Constant Regions Fosters Improved Function of TCR Gene-Modified T Cells
Daniel Sommermeyer et al.
JOURNAL OF IMMUNOLOGY (2010)
Novel Approach to the Formulation of an Epstein-Barr Virus Antigen-Based Nasopharyngeal Carcinoma Vaccine
Viviana P. Lutzky et al.
JOURNAL OF VIROLOGY (2010)
Processing of Two Latent Membrane Protein 1 MHC Class I Epitopes Requires Tripeptidyl Peptidase II Involvement
Jan Diekmann et al.
JOURNAL OF IMMUNOLOGY (2009)
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions
Paul F. Robbins et al.
JOURNAL OF IMMUNOLOGY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines
Yangbing Zhao et al.
JOURNAL OF IMMUNOLOGY (2007)
Targeting the Wilms tumor antigen 1 by TCR gene transfer:: TCR variants improve tetramer binding but not the function of gene modified human T cells
Sharyn Thomas et al.
JOURNAL OF IMMUNOLOGY (2007)
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
Catherine M. Bollard et al.
BLOOD (2007)
Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus:: Human Cytomegalovirus
Elizabeth K. Day et al.
JOURNAL OF IMMUNOLOGY (2007)
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond
Cyrille J. Cohen et al.
CANCER RESEARCH (2007)
Facilitating matched pairing and expression of TCR chains introduced into human T cells
Jurgen Kuball et al.
BLOOD (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
CD8α coreceptor to improve TCR gene transfer to treat melanoma:: Down-regulation of tumor-specific production of IL-4, IL-5, and IL-10
Ralph A. Willemsen et al.
JOURNAL OF IMMUNOLOGY (2006)
Generation of T cell help through a MHC class I-Restricted TCR
Helmut W. H. G. Kessels et al.
JOURNAL OF IMMUNOLOGY (2006)
Generation of tumor-specific T-cell therapies
E Morris et al.
BLOOD REVIEWS (2006)
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells
SA Xue et al.
BLOOD (2005)
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma
KC Straathof et al.
JOURNAL OF IMMUNOLOGY (2005)
Directed evolution of human T-cell receptors with picomolar affinities by phage display
Y Li et al.
NATURE BIOTECHNOLOGY (2005)
Cellular immunotherapy for viral infection after HSC transplantation
P Moss et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
MHM Heemskerk et al.
BLOOD (2003)
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens
RA Morgan et al.
JOURNAL OF IMMUNOLOGY (2003)
Retroviral vectors for high-level transgene expression in T lymphocytes
B Engels et al.
HUMAN GENE THERAPY (2003)
Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCRαβ genes into primary human T lymphocytes
N Schaft et al.
JOURNAL OF IMMUNOLOGY (2003)
CD8- T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation
PD Holler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
T Stanislawski et al.
NATURE IMMUNOLOGY (2001)
Immunotherapy through TCR gene transfer
HWHG Kessels et al.
NATURE IMMUNOLOGY (2001)
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
LJN Cooper et al.
JOURNAL OF VIROLOGY (2000)
Functional reconstitution of class II MHC-Restricted T cell immunity mediated by retroviral transfer of the αβ TCR complex
K Fujio et al.
JOURNAL OF IMMUNOLOGY (2000)
In vitro evolution of a T cell receptor with high affinity for peptide/MHC
PD Holler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)